Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies

Clinical trial NCT01554371 · COMPLETED

Trial details

NCT number: NCT01554371
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Solid Tumour Breast Cancer Nos Metastatic Recurrent Neuropathy

Start date: 2012-03-27
Primary completion: 2019-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.